Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: A systemic review and meta-analysis

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1465-1475

  Ni, Yingmeng ^a   Shi, Guochao ^a   Yu, Youchao ^a   Hao, Jimin ^a   Chen, Tiantian ^a   Song, Huihui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bronchiectasis; Chronic obstructive pulmonary disease; Meta analysis; Phenotype

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; AUTACOID;

AGE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FUNCTION; OBSERVATIONAL STUDY; PHENOTYPE; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SEX DIFFERENCE; SMOKING; SPUTUM ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; FEMALE; IMMUNOLOGY; LUNG; LUNG FUNCTION TEST; MALE; META ANALYSIS; MICROBIOLOGY; ODDS RATIO; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SPUTUM; X-RAY COMPUTED TOMOGRAPHY;

BRONCHIECTASIS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LUNG; MALE; ODDS RATIO; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEX FACTORS; SMOKING; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938391716     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S83910     Document Type: Article

References (45)

1. Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011;140(3):634–642.
2. O’Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55(8):635–642.
3. Roche N, Kouassi B, Rabbat A, et al. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Respiration. 2007;74(1):19–25.
4. Gatheral T, Kumar N, Sansom B, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014; 11(6):605–614.
5. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2014. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdf. Accessed October 10, 2014.
6. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2014. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Apr2.pdf. Accessed May 11, 2015.
7. Martínez-García MÁ, Soler-Cataluña JJ, Donat Sanz Y, et al. Factors associated with bronchiectasis in patients with COPD. Chest. 2011;140(5):1130–1137.
8. Parr DG, Guest PG, Reynolds JH, et al. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. American Journal of Respiratory and Critical Care Medicine. 2007;176(12):1215–1221.
9. Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2004;170(4):400–407.
10. Garcia-Vidal C, Almagro P, Romaní V, et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. European Respiratory Journal. 2009;34(5):1072–1078.
11. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006;11(6):731–740.
12. Tulek B, Kivrak AS, Ozbek S, et al. Phenotyping of chronic obstructive pulmonary disease suing the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J. 2013;20(2):91–96.
13. Martínez-García MA, de la Rosa Carrillo D, Soler-Cataluña JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2013;187(8):823–831.
14. Gallego M, Pomares X, Espasa M, et al. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. BMC Pulmonary Medicine. 2014;14:103.
15. Goeminne PC, Nawrot TS, Ruttens D, et al. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respiratory Medicine. 2014;108(2):287–296.
16. Lin SH, Ji BC, Shi YM, et al. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients. Int J Tuberc Lung Dis. 2013;17(12):1638–1644.
17. Kim SS, Seo JB, Lee YH, et al. Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by using standard images–comparison with quantitative CT and pulmonary function test in the COPD gene study. Radiology. 2013;266(2):626–635.
18. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341.
19. Rostom A, Dube C, Cranney A, et al. Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep. (Evidence Reports/Technology Assessments, No 104.) Appendix D. Quality Assessment Forms. Available from: http://www.ncbi.nlm.nih.gov/books/NBK35156
20. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23(9):1351–1375.
21. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology. 2005;5:13.
22. Gon calvesa JR, Pereirab MC, De Cerqueiraa EP, et al. Severe obstructive disease: Similarities and differences between smoker and non-smoker patients with COPD and/or bronchiectasis. Rev Port Pneumol. 2013;19(1):13–18.
23. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379–387.
24. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179:783–788.
25. Han MK, Bartholmai B, Liu LX, et al. Clinical significance of radiologic characterizations in COPD. COPD. 2009;6(6):459–467.
26. Kinsella M, Müller NL, Abboud RT, et al. Quantitation of emphysema by computed tomography using a ‘density mask’ program and correlation with pulmonary function tests. Chest. 1990;97(2):315–321.
27. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. American Journal of Respiratory and Critical Care Medicine. 2000;162(3 Pt 1):1102–1108.
28. Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48(3):86–98.
29. Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J. 2008;31(2):396–406.
30. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000; 343(4):269–280.
31. Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax. 1952;7(3):213–239.
32. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653.
33. Agusti A, Calverley PM, Celli B, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
34. Boucher RC. Relationship of airway epithelial ion transport to chronic bronchitis. Proc Am Thorac Soc. 2004;1(1):66–70.
35. Reid LM. Reduction in bronchial subdivision in bronchiectasis. Thorax. 1950;5(3):233–247.
36. Hansell DM, Wells AU, Rubens MB, Cole PJ. Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT. Radiology. 1994;193(2):369–374.
37. Novosad SA, Barker AF. Chronic obstructive pulmonary disease and bronchiectasis. Curr Opin Pulm Med. 2013;19(2):133–139.
38. Cole PJ. Inflammation: a two-edged sword the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6–15.
39. Engler K, Mühlemann K, Garzoni C, et al. Colonization with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients. Swiss Med Wkly. 2012;142:w13509.
40. Patel IS1, Seemungal TA, Wilks M, et al. Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57(9):759–764.
41. Groenewegen KH, Wouters EF. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med. 2003;97(7):770–777.
42. Marin A, Monsó E, Garcia-Nuñez M, et al. Variability and effects of bronchial colonization in patients with moderate COPD. Eur Respir J. 2010;35(2):295–302.
43. Almagro P, Salvadó M, Garcia-Vidal C, et al. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease. Respiration. 2012;84(1):36–43.
44. Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. Eur Respir J. 2015;45(2):310–313.
45. Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J. 2011; 20(2):135–140.